Skip to main content

Table 1 Clinical and genetic characteristics of the series of 13 Serbian APECED patients including two novel case reports

From: Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?

Patient

Sex/age at referral (years)

Age of first symptom (years)

AIRE mutation

Major clinical manifestations related to APECEDe

Other clinical manifestationse

Reference

a, d1.

M/3.5

3.5

c.769C > T

R257X (p.Arg257X)

Addison’s disease (3.5)

Hypoparathyroidism (4)

 

Present report

a, d2.

F/4

4

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis

Hypoparathyroidism (4)

Addison’s disease (11)

Ectodermal dystrophy

Diffuse alopecia with madarosis

Onychomycosis

Hashimoto’s thyroiditis (13.5)

POF (16)

Present report

a, c, d3.

F/33

7

c.769C > T

R257X (p.Arg257X)

Hypoparathyroidism (7)

Addison’s disease (14)

Mucocutaneous candidiasis (16)

Pure red cell aplasia

Hashimoto’s thyroiditis

POF (30)

Renal dysfunction

Exocrine pancreas insufficiency (36)

[15]

4.(younger sister of patient 3)

F

 

c.769C > T

R257X (p.Arg257X)

Chronic mucocutaneous candidiasis

Hypoparathyroidism

Addison’s disease

Pernicious anemia

Lichen ruber planus

[15]

a, d5.

  

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis

Addison’s disease

Vitiligo

Alopecia

Ectodermal dystrophy

Autoimmune hepatitis

[16]

6.

F/21

7.5

p.Glu298Lys/

p.Arg257X

c.892G > A/

c.769C > T

Hypoparathyroidism (7.5)

Addison’s disease (8)

Mucocutaneous candidiasis (11)

Autoimmune bronchiolitis (3.5)

Hypogonadism (12)

Chronic Otitis media with effusion (16.5)

Systemic Juvenile Rheumatoid Arthritis

Pernicious anemia (17)

[17]

a, b, c7.

M/12

2

p. (=)/

p.Arg257X

c.462A > T/

c.769C > T

Addison’s disease (11)

Ectodermal dystrophy (2)

Malabsorption (2)

Vitiligo (2)

Alopecia (2.5)

[17]

8.

F/8

1

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (1)

Addison’s disease (4)

Hypoparathyroidism (5)

Vitiligo (1)

[17]

a, c, d9.

F/22

5

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (5)

Addison’s disease (16)

Hypoparathyroidism (15)

Chronic hepatitis (15)

Pernicious anemia (16)

[17]

a, b, c10.

M/20

6

c.769C > T

R257X

(p. Arg257X)

Mucocutaneous candidiasis (6)

Hypoparathyroidism (9)

Addison’s disease (11)

Malabsorption (9)

[17]

a, c11.

F/23

9

c.769C > T

R257X (p.Arg257X)

Hypoparathyroidism (9)

Mucocutaneous candidiasis (10)

Addison’s disease (10)

Alopecia (10)

Hypogonadism (18)

[17]

a, b, c12.

M/19

10

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (11)

Hypoparathyroidism (13)

Addison’s disease (14)

Pernicious anemia (10)

Malabsorption (11)

Alopecia (13)

[17]

a, c13.

F/20

15

not available

Adrenal insufficiency (15)

Hypoparathyroidism (15)

Graves’ disease (15)

Vitiligo (15)

POF (15)

Alopecia universalis (18)

Vogt-Koyanagi-Harada syndrome (20)

[18]

  1. aAPECED patients for which sufficient information is retrospectively available to support a clinical diagnosis also based on the presence of Ferre/Lionakis criteria (i.e., presence of one symptom of the classic triad and one symptom of the adjunct triad of urticarial eruption, intestinal dysfunction and enamel hypoplasia). N = 10
  2. bPatients for which sufficient information is retrospectively available and it was possible to confirm an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria. N = 3
  3. cPatients for which sufficient information is retrospectively available to verify whether an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria was possible. N = 7
  4. dIncompletely evaluable patients for an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria due to lack of information on the age of appearance of symptoms. N = 5
  5. eAge of appearance of symptom (years)